Geftib 250 mg Tablet
$52,16
$15,78
Geftib 250 mg Tablet is an effective treatment option for adult patients diagnosed with non-small cell lung cancer (NSCLC) that has metastasized to other areas of the body, particularly in individuals with specific abnormalities in the EGFR gene who have not previously undergone cancer therapy. This targeted therapy works by inhibiting the growth of cancer cells, helping to slow disease progression and improve overall outcomes. It is important to note that Geftib is not recommended for use in children or adolescents due to insufficient data regarding its safety and efficacy in these age groups. Patients should be aware of potential side effects, which may include gastrointestinal issues, skin reactions, and respiratory problems. Regular monitoring by healthcare professionals is crucial to manage any adverse effects effectively. As with any medication, it is essential to discuss your full medical history with your doctor before starting treatment with Geftib 250 mg Tablet. By targeting specific genetic mutations, this medication represents a promising advancement in the management of advanced NSCLC, providing hope for improved survival rates in eligible patients.
數量
Active Pharmaceutical Ingredient
Uses
• Geftib 250 mg tablet is primarily used for the treatment of non-small cell lung cancer. This type of lung cancer affects a large portion of lung tissue and can be challenging to manage. The active components in Geftib 250 mg tablet target specific pathways involved in the growth of cancer cells. By inhibiting these pathways, the medication helps to slow the progression of the disease.
• Patients with advanced non-small cell lung cancer often benefit from the use of Geftib 250 mg tablet. In cases where the cancer has spread beyond the lungs, this medication can play a crucial role in managing symptoms and improving quality of life. Geftib 250 mg tablet works by blocking signals that promote tumor growth. This targeted approach can lead to better treatment outcomes for individuals facing this condition.
• Geftib 250 mg tablet may also be utilized in patients who have previously undergone other treatments for non-small cell lung cancer. When first-line therapies are ineffective, healthcare providers may prescribe Geftib 250 mg tablet as a second-line option. This helps to provide an alternative treatment pathway for patients who need additional support. The effectiveness of Geftib 250 mg tablet in these scenarios can be significant in maintaining patient health.
• In some cases, Geftib 250 mg tablet is indicated for patients with specific genetic mutations associated with non-small cell lung cancer. Testing for these mutations can guide treatment decisions and enhance the efficacy of therapy. When used appropriately, Geftib 250 mg tablet can effectively target cancer cells harboring these mutations. This precision medicine approach allows for more tailored treatment strategies in oncology.
Benefits
Geftib Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Geftib 250 Tablet may help to slow the progression of cancer.
Geftib 250 mg may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.
Geftib Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
As with all medicines, Geftib 250 mg Tablet may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
Common Side Effects
• Liver Damage
• Seizures
• Infection
• Kidney Damage
• Memory Problems
• Vision Problems
• Sleeplessness
How To Use
It is recommended to consume Geftib 250 mg Tablet with or without food. Be sure to swallow the tablet whole with a complete glass of water. Avoid crushing, chewing, or opening the tablet. In case you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and adhere to your regular dosing schedule. Remember not to take two doses simultaneously to compensate for a missed dose.
Safety Advice
• Alcohol: The use of alcohol is generally not recommended while taking Geftib 250 mg Tablet as it may increase the risk of liver damage. It is advisable to either abstain from alcohol or limit your alcohol intake while taking any medication.
• Kidney: Geftib 250 mg Tablet is considered safe for patients with mild to moderate kidney disease and no dose adjustment of Geftib 250 mg is required. However, people with severe kidney disease are advised not to take Geftib 250 Tablet Tablet. To ensure the safety and effectiveness of your treatment, it is important to have an open discussion with your doctor about all your medical conditions and medications.
• Breastfeeding: It is not advisable to breast-feed while taking Geftib 250 Tablet as this may cause harm to the baby. Geftib 250 mg Tablet can pass into breast milk and cause adverse effects. If you are currently breastfeeding and using Geftib Tablet, it is important to discuss with your doctor the potential risks and benefits of continuing to breastfeed. Your doctor will help you make the decision that is best for you and your baby.
• Liver: Geftib 250 mg Tablet is considered safe for patients with mild to moderate liver disease, and there is no need to adjust the dose of Geftib Tablet. However, people with severe liver disease should not use Geftib 250 mg Tablet. It is important to have an open discussion with your doctor about your medical conditions and medications to ensure that the treatment plan is appropriate for you.
• Pregnancy: Geftib 250 mg Tablet may be unsafe during pregnancy as animal studies suggest that it may harm the developing fetus. However, if you are pregnant or planning to get pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Geftib 250 mg Tablet while pregnant. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Driving: Geftib 250 mg Tablet may cause dizziness, drowsiness, and problems with concentration and coordination, which may impair your ability to drive a vehicle safely. It is important that you follow your doctor's instructions and take the necessary measures, such as avoiding driving or operating heavy machinery, if you experience any of these side effects caused by Geftib Tablet.